New Delhi: The advertisements of oral hygiene brand Sensodyne’s products, which make the claims of ‘Recommended by dentists worldwide’ and ‘World’s No.1 sensitivity toothpaste’ will soon go off air.

If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate commission. Related story It’s Official! These Are the Top 21 Toys of 2025 ...

Toronto, ON, May 26, 2025 (GLOBE NEWSWIRE) -- With National Smile Day around the corner, new research from Sensodyne, the #1 dentist-recommended brand for sensitive teeth, reveals that more than 80 ...

(Reuters) -Haleon, the world's biggest standalone consumer health business, is planning to cut hundreds of roles in the UK and worldwide, the Guardian reported on Thursday. The company behind the ...

The Department of Health (DOH) will investigate whether Sensodyne, a brand of toothpaste, was sold to the public without the ingredients and warning clearly listed on the packaging, a health official ...

Select independently determines what we cover and recommend. When you buy through our links, we may earn a commission. Learn more. You shouldn’t experience tooth pain when you eat a spoonful of ice ...

Toxic chemicals have been found in fake Sensodyne toothpaste sold at discount shops, markets and car boot sales. Tubes of original and mint flavour contain toxic levels of diethylene glycol, the ...

An official release on Tuesday stated that advertisements of Sensodyne products which make the claims 'Recommended by dentists worldwide' and 'World's No.1 sensitivity toothpaste' have been ordered to ...

The Central Consumer Protection Authority (CCPA) recently passed an order against misleading advertisements of Sensodyne products which make claims such as, “Recommended by dentists worldwide” and ...

Sensodyne wanted to do more than just get a sense of whether people were paying attention to its TV ads. The Haleon-owned toothpaste brand also wanted to optimize for attention. But that’s a challenge ...

In a big relief to GlaxoSmithKline (GSK), the Delhi High Court has stayed the Drug Controller General of India’s (DCGI) decision to cancel its licence held by Global Health Care Products (GHCP) for ...